Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury.
about
Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational modelDevelopment of a universal measure of quadrupedal forelimb-hindlimb coordination using digital motion capture and computerised analysisSpinal cord injury II: Prognostic indicators, standards of care, and clinical trialsSynaptically-competent neurons derived from canine embryonic stem cells by lineage selection with EGF and Noggin.Naturally occurring disk herniation in dogs: an opportunity for pre-clinical spinal cord injury researchPilot study: bone marrow stem cells as a treatment for dogs with chronic spinal cord injury.Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy.Expression of neurotrophic factors in injured spinal cord after transplantation of human-umbilical cord blood stem cells in rats.Changes of the Electrophysiological Study in Dogs with Acute Spinal Cord InjuryCanine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury.Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury.Construction of pathways to promote axon growth within the adult central nervous system.Mechanisms of injury and emergency care of acute spinal cord injury in dogs and cats.Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease.Targeting Translational Successes through CANSORT-SCI: Using Pet Dogs To Identify Effective Treatments for Spinal Cord Injury.Toward defining the regenerative potential of olfactory mucosa: establishment of Schwann cell-free adult canine olfactory ensheathing cell preparations suitable for transplantation.Spatio-temporal development of axonopathy in canine intervertebral disc disease as a translational large animal model for nonexperimental spinal cord injury.Site-specific population dynamics and variable olfactory marker protein expression in the postnatal canine olfactory epithelium.A fusion of minicircle DNA and nanoparticle delivery technologies facilitates therapeutic genetic engineering of autologous canine olfactory mucosal cells.Adaptation of the Basso-Beattie-Bresnahan locomotor rating scale for use in a clinical model of spinal cord injury in dogs.Transcriptional profiling predicts overwhelming homology of Schwann cells, olfactory ensheathing cells, and Schwann cell-like glia.Increased p75 neurotrophin receptor expression in the canine distemper virus model of multiple sclerosis identifies aldynoglial Schwann cells that emerge in response to axonal damage.Serum-Free Medium Provides a Clinically Relevant Method to Increase Olfactory Ensheathing Cell Numbers in Olfactory Mucosa Cell Culture.Generation and characterization of highly purified canine Schwann cells from spinal nerve dorsal roots as potential new candidates for transplantation strategies.The collagen scaffold with collagen binding BDNF enhances functional recovery by facilitating peripheral nerve infiltrating and ingrowth in canine complete spinal cord transection.Bridging the gap with functional collagen scaffolds: tuning endogenous neural stem cells for severe spinal cord injury repair.
P2860
Q30528505-1E133C3C-C076-41BA-BE05-E1C148BE9C57Q33299393-6814AF25-1AE9-4C45-B71C-B272E27B3B08Q33854697-91D15C99-5DCC-47CB-B429-235208B47A44Q33911327-51CF0AC6-DFA8-42AF-99AC-3287AF8B993CQ34757608-05007200-4743-4A1B-BBB1-92EFC00A6053Q35576889-D2B9EA90-A0FF-4866-B611-24C0A0C44745Q35702252-2CA696DC-6820-4A9E-868C-529401AB0BF9Q36415316-FF51CE9D-0903-48A0-BB8B-34F7E502519DQ36731478-77B64879-A47F-4872-8DFD-FA75D0C6F2DDQ36856344-4B71C7F9-0AB9-4077-9F59-AFC79624508EQ37635473-D08BCB9B-C960-4972-BF4A-89495535DE99Q37681696-7B81452B-23B3-4B7D-A813-ABAE8E5F000FQ37765694-53B2D21B-7C25-418A-8ADA-E9E4945D48D3Q38046994-AA4AE05B-AF56-43C3-8194-34B2DC5ED64FQ38244902-E36AC345-905F-491B-9D3F-9D9CC7ED4B18Q39147798-93FE17E0-2012-4E04-9F57-CDF42AEE3953Q39548069-CAC0FF82-C6A3-4D5D-BE68-2597260ACCD8Q39584706-AC45FE68-0991-458C-B131-C908E543FB5BQ39943288-04E30C4B-91BA-4C89-8CF9-4B15B93FDC24Q40160514-5BDF9D3D-215C-43B6-B6C8-B8F333CC2CF7Q41952978-87039E38-3DD2-401E-8D8F-00B862BED597Q42215028-DD29932B-7003-4AC1-8D82-5B0F09F60E90Q45361860-E6D9DEF0-DC37-43B0-AD8F-ED7E1AC79F94Q47834884-46B06F83-7724-45B1-BD59-38D84B0B9242Q48135676-364D857A-12A4-4DCE-980C-B54CD67C42F1Q48486544-EFB1EB2C-E27A-4A5D-A571-100C78F254D3Q49627022-3A65970C-478A-477D-886F-8C8CAEF6262A
P2860
Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@en
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@nl
type
label
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@en
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@nl
prefLabel
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@en
Autologous olfactory glial cel ...... ing canine spinal cord injury.
@nl
P356
P1476
Autologous olfactory glial cel ...... ring canine spinal cord injury
@en
P2093
Andras Lakatos
P304
P356
10.1089/NEU.2005.22.1282
P577
2005-11-01T00:00:00Z